DEUTSCHE BANK AG\ – BioMarin Pharmaceutical Inc. Transaction History
DEUTSCHE BANK AG\ portfolio value:
$187.64M
portfolio value
DEUTSCHE BANK AG\ quarter portfolio value change:
+2.29%
quarter
BioMarin Pharmaceutical Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +80.47% | 986.99K shares | 85.99M | $84.77 | 2.21M |
| Q2 2022 | share | Increase | +37.64% | 335.39K shares | 32.93M | $82.87 | 1.22M |
| Q1 2022 | share | Decrease | -5.30% | -49.91K shares | -14.43M | $77.1 | 891.18K |
| Q4 2021 | share | Increase | +5.40% | 48.21K shares | 14.13M | $89.08 | 941.09K |
| Q3 2021 | share | Decrease | -24.13% | -284.01K shares | -29.18M | $77.29 | 892.87K |
| Q2 2021 | share | Increase | +3.41% | 38.8K shares | 12.26M | $83.44 | 1.17M |
| Q1 2021 | share | Increase | +7.53% | 79.71K shares | -6.87M | $75.51 | 1.13M |
| Q4 2020 | share | Decrease | -22.95% | -315.17K shares | -11.69M | $87.69 | 1.05M |
| Q3 2020 | share | Decrease | -7.94% | -118.50K shares | -79.53M | $76.08 | 1.37M |
| Q2 2020 | share | Increase | +0.59% | 8.74K shares | 58.68M | $123.34 | 1.49M |
| Q1 2020 | share | Increase | +14.00% | 182.13K shares | 15.33M | $84.5 | 1.48M |
| Q4 2019 | share | Increase | +6.89% | 83.89K shares | 27.97M | $84.55 | 1.30M |
| Q3 2019 | share | Decrease | -23.07% | -365.10K shares | -53.48M | $67.4 | 1.21M |
| Q2 2019 | share | Increase | +13.61% | 189.62K shares | 11.81M | $85.65 | 1.58M |
| Q1 2019 | share | Increase | +55.05% | 494.51K shares | 47.23M | $88.83 | 1.39M |
| Q4 2018 | share | Decrease | -9.32% | -92.29K shares | -19.56M | $85.15 | 898.26K |
| Q3 2018 | share | Increase | +0.64% | 6.32K shares | 3.33M | $96.97 | 990.55K |
| Q2 2018 | share | Decrease | -21.13% | -263.71K shares | -8.45M | $94.2 | 984.23K |
| Q1 2018 | share | Increase | +21.12% | 217.64K shares | 9.3M | $81.07 | 1.24M |
| Q4 2017 | share | Decrease | -25.99% | -361.77K shares | -37.69M | $89.17 | 1.03M |
| Q3 2017 | share | Increase | +1.69% | 23.14K shares | 5.23M | $93.07 | 1.39M |
| Q2 2017 | share | Increase | +2.99% | 39.72K shares | 7.64M | $90.82 | 1.36M |
| Q2 2017 | call | Decrease | -100.00% | -500 shares | -43K | $90.82 | 0 |
| Q1 2017 | call | Increase | +380.77% | 396 shares | 35K | $87.78 | 500 |
| Q1 2017 | share | Decrease | -8.62% | -125.34K shares | -3.81M | $87.78 | 1.32M |
| Q4 2016 | share | Decrease | -6.21% | -96.35K shares | -22.99M | $82.84 | 1.45M |
| Q4 2016 | put | Decrease | -100.00% | -594 shares | -54K | $82.84 | 0 |
| Q4 2016 | call | Decrease | -83.33% | -520 shares | -49K | $82.84 | 104 |
| Q3 2016 | call | Increase | 0.00% | 624 shares | 57K | $92.52 | 624 |
| Q3 2016 | put | Increase | 0.00% | 594 shares | 54K | $92.52 | 594 |
| Q3 2016 | share | Increase | +12.47% | 171.98K shares | 36.21M | $92.52 | 1.55M |
| Q2 2016 | share | Increase | +3.27% | 43.66K shares | -2.85M | $77.8 | 1.37M |
| Q1 2016 | share | Increase | +19.57% | 218.53K shares | -6.85M | $82.48 | 1.33M |